Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7RH7

Mycobacterial CIII2CIV2 supercomplex, Telacebec (Q203) bound

Summary for 7RH7
Entry DOI10.2210/pdb7rh7/pdb
EMDB information24455 24456 24457
DescriptorLpqE protein, Cytochrome bc1 complex cytochrome c subunit, Cytochrome bc1 complex cytochrome b subunit, ... (24 entities in total)
Functional Keywordselectron transport chain, ciii2civ2 supercomplex, membrane protein
Biological sourceMycolicibacterium smegmatis MC2 155
More
Total number of polymer chains24
Total formula weight713342.31
Authors
Di Trani, J.M.,Yanofsky, D.J.,Rubinstein, J.L. (deposition date: 2021-07-16, release date: 2021-08-04, Last modification date: 2024-11-13)
Primary citationYanofsky, D.J.,Di Trani, J.M.,Krol, S.,Abdelaziz, R.,Bueler, S.A.,Imming, P.,Brzezinski, P.,Rubinstein, J.L.
Structure of mycobacterial CIII 2 CIV 2 respiratory supercomplex bound to the tuberculosis drug candidate telacebec (Q203).
Elife, 10:-, 2021
Cited by
PubMed Abstract: The imidazopyridine telacebec, also known as Q203, is one of only a few new classes of compounds in more than 50 years with demonstrated antituberculosis activity in humans. Telacebec inhibits the mycobacterial respiratory supercomplex composed of complexes III and IV (CIIICIV). In mycobacterial electron transport chains, CIIICIV replaces canonical CIII and CIV, transferring electrons from the intermediate carrier menaquinol to the final acceptor, molecular oxygen, while simultaneously transferring protons across the inner membrane to power ATP synthesis. We show that telacebec inhibits the menaquinol:oxygen oxidoreductase activity of purified CIIICIV at concentrations similar to those needed to inhibit electron transfer in mycobacterial membranes and growth in culture. We then used electron cryomicroscopy (cryoEM) to determine structures of CIIICIV both in the presence and absence of telacebec. The structures suggest that telacebec prevents menaquinol oxidation by blocking two different menaquinol binding modes to prevent CIIICIV activity.
PubMed: 34590581
DOI: 10.7554/eLife.71959
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3 Å)
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon